马萨诸塞州剑桥市 - mRNA疗法和疫苗领域的先驱Moderna Inc (NASDAQ:MRNA)今日宣布，前Vifor Pharma首席执行官和葛兰素史克制药和疫苗全球总裁Abbas Hussain已被任命为公司董事会成员。

On Saturday, Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer cachexia during the European Society for Medical Oncology 2024 ...

The CNBC host said that he has reminded his viewers repeatedly that when the Fed is your “enemy” you should stick to ...

马萨诸塞州剑桥市 - Moderna Inc (NASDAQ:MRNA) 已启动其诺如病毒疫苗候选物的3期临床试验，这标志着解决该病毒所带来的广泛公共卫生问题迈出了重要一步。今天，美国第一位参与者接受了疫苗候选物mRNA-1403的剂量，作为Nova ...

Cartesian Therapeutics is a clinical-stage company developing mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is an mRNA CAR-T in Phase 2b ...

CAMBRIDGE, MA and TAIPEI, TAIWAN / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Cenra Healthcare, the sales and marketing ...

Shares of NASDAQ MRNA opened at $68.28 on Friday. The stock has a market cap of $26.17 billion, a P/E ratio of -4.36 and a beta of 1.67. Moderna has a twelve month low of $62.55 and a twelve month ...

Shares of NASDAQ:MRNA traded up $0.58 during trading on Thursday, hitting $70.44. 261,637 shares of the company were exchanged, compared to its average volume of 4,233,954. The business’s 50 day ...

Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning ...

Investing.com – 美国股市在星期二涨跌不一，其中石油和天然气、消费服务和金融等上涨的板块带领股指走高；与此同时，电信、卫生保健和生活消费品板块等下跌的使股指走低。 纽约收盘时，道琼斯工业平均指数下跌0.04%，而标准普尔500指数上涨0 ...

CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the U.S. has been dosed in the Nova 301 Trial, a pivotal Phase 3 randomized ...